Delivery Order SPE2DR25D2014-SPE2DR26FZ95D
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $32,549.15 delivery order by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 12, 2025, and represents a child delivery order under a larger contract vehicle. The award carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain has awarded AmerisourceBergen Drug Corp a delivery order valued at $38,089.85 for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed-price contract. This non-set-aside award, announced on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $14,201.99 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (60-count package). This competitive award, announced on October 23, 2025, with an ultimate completion date of October 24, 2025, represents a firm fixed price transaction with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $12,731.13 from the Defense Logistics Agency (DLA) on December 10, 2025, with an ultimate completion date of December 11, 2025. The contract covers the supply of Entresto 24 mg-26 mg tablets in a quantity of 180 units. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,494.76 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180 count) on September 22, 2025, with an ultimate completion date of September 23, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count) at a firm fixed price of $5,740.94, with completion due by November 14, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a $2,060.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count supply). This non-set-aside delivery order, with an ultimate completion date of April 30, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger pharmaceutical supply vehicle with...
- The Defense Logistics Agency awarded a delivery order valued at $58,421.75 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count units) with a firm fixed price structure. The contract is non-competitive set-aside and carries an ultimate completion date of December 2, 2025. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on May 20, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count). This non-set-aside, competitively awarded contract carries a ceiling value of $3,284.36 and is priced on a firm fixed-price basis, with an ultimate completion date of May 21, 2025. The delivery order represents a task against AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,494.76 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count). The contract, issued May 30, 2025, with an ultimate completion date of June 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order under its substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ95DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $37,060.03 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (60-count units) on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent IDC vehicle serves as a global pharmaceutical support mechanism enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its extensive portfolio of pharmaceutical deliveries under the DLA Medical Supply Chain, positions the company as a primary vendor for federal healthcare procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.1k | 12/10/25 |